BHARAT SERUM & VACCINES

Mankind Pharma in race with PEs to buy BSV Group at possible valuation of Rs 13,000 crore

Dr Reddy’s Laboratories may also join the fray, having sought extra time to submit a bid for the Advent International portfolio company, the people added, saying its non-binding bid is expected to be filed this week. Due diligence will continue over the next four to six weeks, before the final offers are submitted in July.